Etracker Debug:
	et_pagename = "Clinical Chemistry and Laboratory Medicine (CCLM)|cclm|C|[EN]"
	
        
Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Editorial Board Member: Gillery, Philippe / Kazmierczak, Steven / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Whitfield, John B.

13 Issues per year

IMPACT FACTOR 2013: 2.955
Rank 5 out of 29 in category Medical Laboratory Technology in the 2013 Thomson Reuters Journal Citation Report/Science Edition

VolumeIssuePage

Issues

Concentrations of homocysteine, related metabolites and asymmetric dimethylarginine in preeclamptic women with poor nutritional status

Wolfgang Herrmann1 / Sonia Isber2 / Rima Obeid3 / Markus Herrmann4 / Muhidien Jouma5

1.

2.

3.

4.

5.

Corresponding author: Prof. Dr. Wolfgang Herrmann, Zentrallabor der Universitätskliniken des Saarlandes, Gebäude 57, 66421 Homburg, Germany Phone: +49-6841-1630700, Fax: +49-6841-1630703,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 43, Issue 10, Pages 1139–1146, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2005.198, October 2005

Abstract

Background: Hyperhomocysteinemia, a proxy measure for the nutritional status of the B vitamins, may be involved in the etiology of preeclampsia via inducing endothelial dysfunction. Asymmetric dimethylarginine (ADMA) is an inhibitor of NO-synthase that may adversely affect the endothelium.

Materials and methods: We investigated serum concentrations of folate, vitamin B12, B6, homocysteine (Hcy) and related metabolites in 139 Syrian preeclamptic women and 93 asymptomatic pregnant women of comparable age, gestational age and socioeconomic status. Plasma concentrations of ADMA were determined in a subset of age- and gestation-age-matched pairs of patients and controls (n=63).

Results: Higher concentrations of Hcy, cystathionine and methylmalonic acid (MMA) were closely linked to a lower status of the B vitamins. Higher concentrations of Hcy and cystathionine were observed in the preeclamptic group than in the matched controls (median Hcy 9.3 vs. 6.0 μmol/L; median cystathionine 284 vs. 232 nmol/L). Serum folate was significantly lower in patients than in controls (16.4 vs. 36.0 nmol/L). Folate supplementation was less likely to be used in preeclamptic women. Concentrations of MMA were elevated in patients and controls and did not differ significantly between the two groups. Median plasma concentrations of ADMA were significantly lower in asymptomatic women than in those who developed preeclampsia before the 37th week of gestation (0.61 vs. 0.68 μmol/L).

Conclusions: Elevated serum concentrations of Hcy, cystathionine and MMA indicate poor status of the B vitamins during pregnancy. The adverse effect of Hcy on endothelial function might be related to ADMA in early-onset preeclampsia. More emphasis should be placed on increasing the intake of B vitamins in pregnant women from developing countries.

Keywords: asymmetric dimethylarginine; folate; homocysteine; preeclampsia

Comments (0)

Please log in or register to comment.
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.